Projecting survival in papillary thyroid cancer: a comparison of the seventh and eighth editions of the American Joint Commission on Cancer/Union for International Cancer … LN Pontius, TO Oyekunle, SM Thomas, MT Stang, RP Scheri, SA Roman, ... Thyroid 27 (11), 1408-1416, 2017 | 92 | 2017 |
Recurrent laryngeal nerve injury after thyroid surgery: an analysis of 11,370 patients A Gunn, T Oyekunle, M Stang, H Kazaure, R Scheri Journal of Surgical Research 255, 42-49, 2020 | 71 | 2020 |
A direct comparison of the ATA and TI-RADS ultrasound scoring systems S Ahmadi, T Oyekunle, R Scheri, J Perkins, M Stang, S Roman, JA Sosa Endocrine Practice 25 (5), 413-422, 2019 | 49 | 2019 |
Severe hypocalcemia after thyroidectomy: an analysis of 7366 patients HS Kazaure, A Zambeli-Ljepovic, T Oyekunle, SA Roman, JA Sosa, ... Annals of Surgery 274 (6), e1014-e1021, 2021 | 45 | 2021 |
A randomized controlled trial of a 6-month low-carbohydrate intervention on disease progression in men with recurrent prostate cancer: carbohydrate and prostate study 2 (CAPS2) SJ Freedland, J Allen, A Jarman, T Oyekunle, AJ Armstrong, JW Moul, ... Clinical Cancer Research 26 (12), 3035-3043, 2020 | 44 | 2020 |
Using the ATA and ACR TI-RADS sonographic classifications as adjunctive predictors of malignancy for indeterminate thyroid nodules S Ahmadi, R Herbst, T Oyekunle, K Strickland, S Roman, JA Sosa Endocrine Practice 25 (9), 908-917, 2019 | 43 | 2019 |
Obesity, race, and long‐term prostate cancer outcomes AC Vidal, T Oyekunle, LE Howard, AM De Hoedt, CJ Kane, MK Terris, ... Cancer 126 (16), 3733-3741, 2020 | 42 | 2020 |
Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer T Zhang, A Agarwal, RG Almquist, D Runyambo, S Park, E Bronson, ... Biomarker Research 9, 1-12, 2021 | 33 | 2021 |
Metabolomic effects of androgen deprivation therapy treatment for prostate cancer JT Chi, PH Lin, V Tolstikov, T Oyekunle, EY Chen, V Bussberg, ... Cancer Medicine 9 (11), 3691-3702, 2020 | 28 | 2020 |
Factors affecting the obliteration rate of intracranial aneurysms treated with a single Pipeline embolization device H Moshayedi, OA Omofoye, E Yap, TO Oyekunle, DM Sasaki-Adams, ... World neurosurgery 104, 205-212, 2017 | 28 | 2017 |
Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system N Chereau, TO Oyekunle, A Zambeli-Ljepović, HS Kazaure, SA Roman, ... Journal of British Surgery 106 (7), 889-897, 2019 | 26 | 2019 |
Postoperative radiation therapy for prostate cancer: comparison of conventional versus hypofractionated radiation regimens DJ Tandberg, T Oyekunle, WR Lee, Y Wu, JK Salama, BF Koontz International Journal of Radiation Oncology* Biology* Physics 101 (2), 396-405, 2018 | 23 | 2018 |
Abdominal and pelvic adipose tissue distribution and risk of prostate cancer recurrence after radiation therapy CM Di Bella, LE Howard, T Oyekunle, AM De Hoedt, JK Salama, H Song, ... The Prostate 80 (14), 1244-1252, 2020 | 22 | 2020 |
A nomogram for testosterone recovery after combined androgen deprivation and radiation therapy for prostate cancer DY Spiegel, JC Hong, T Oyekunle, L Waters, WR Lee, JK Salama, ... International Journal of Radiation Oncology* Biology* Physics 103 (4), 834-842, 2019 | 20 | 2019 |
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer LC Brown, S Halabi, JA Somarelli, M Humeniuk, Y Wu, T Oyekunle, ... Prostate Cancer and Prostatic Diseases 25 (4), 762-769, 2022 | 16 | 2022 |
Diabetes and prostate cancer outcomes in obese and nonobese men after radical prostatectomy S Kelkar, T Oyekunle, A Eisenberg, L Howard, WJ Aronson, CJ Kane, ... JNCI cancer spectrum 5 (3), pkab023, 2021 | 16 | 2021 |
Dietary inflammatory index (DII) and risk of prostate cancer in a case–control study among Black and White US Veteran men AC Vidal, T Oyekunle, LE Howard, N Shivappa, A De Hoedt, ... Prostate cancer and prostatic diseases 22 (4), 580-587, 2019 | 15 | 2019 |
A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non … MR Harrison, PG Davis, MG Khouri, DB Bartlett, RT Gupta, AJ Armstrong, ... Prostate cancer and prostatic diseases 25 (1), 58-64, 2022 | 10 | 2022 |
Primary mediastinal (thymic) large B-cell lymphoma: fidelity of diagnosis using WHO criteria A Fairchild, CM McCall, T Oyekunle, D Niedzwiecki, C Champ, ... Clinical Lymphoma Myeloma and Leukemia 21 (5), e464-e469, 2021 | 10 | 2021 |
Sleep quality and prostate cancer aggressiveness: Results from the REDUCE trial EK Wiggins, T Oyekunle, LE Howard, SC Markt, LA Mucci, DL Bliwise, ... The Prostate 80 (15), 1304-1313, 2020 | 9 | 2020 |